SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9481	Companies
185571	Keywords
117977	Articles
99404	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/07/2024 at 17:30, 11 months 30 days ago

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
Positive phase 3 study shows rilzabrutinib benefits in ITP patients. Results include platelet response, reduced bleeding, improved quality of life. Safety and efficacy highlighted

Phase 3 Study Rilzabrutinib ITP BTK Inhibitor Patient Benefit
BRIEF

published on 12/06/2024 at 07:35, 1 year ago

Sanofi Publishes Revised Financial Statements Excluding Opella

Financial Statements Biopharma Sanofi 2024 Results Opella
BRIEF

published on 12/06/2024 at 07:35, 1 year ago

Sanofi publie ses états financiers révisés excluant Opella

États Financiers Résultats 2024 Biopharma Sanofi Opella
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Sanofi releases revised financial statements excluding Opella. The adjustments classify Opella as discontinued operations, aligning with Sanofi's transition to a biopharma company. Q4 2024 results expected on Jan 30, 2025

Sanofi Discontinued Operations Opella Revised Financial Statements Biopharma Company
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year ago

Communiqué de presse : Mise en ligne des états financiers révisés de Sanofi hors Opella
Publication des états financiers révisés de Sanofi, hors Opella, suite à la cession de 50% à CD&R. Sanofi se recentre sur la biopharmacie et l'innovation

Cession États Financiers Sanofi Opella Biopharmacie
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 1 month ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 1 month ago

Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance
BRIEF

published on 10/24/2024 at 14:05, 1 year 1 month ago

Positive Phase 3 Data for Dupixent in Chronic Spontaneous Urticaria Released

Dupixent Chronic Spontaneous Urticaria Phase 3 Data ACAAI Presentation Treatment Innovation
BRIEF

published on 10/24/2024 at 14:05, 1 year 1 month ago

Publication de données positives de phase 3 pour Dupixent dans l'urticaire chronique spontanée

Dupixent Urticaire Chronique Spontanée Données De La Phase 3 Présentation De L'ACAAI Innovation En Matière De Traitement
PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 1 month ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent phase 3 data in chronic spontaneous urticaria presented at ACAAI shows reduced itch and hive activity, potential new treatment for CSU patients

Dupixent Chronic Spontaneous Urticaria ACAAI Phase 3 Data Targeted Treatment

Accesswire

Published on 12/06/2025 at 02:00, 15 hours 50 minutes ago

Northern Dynasty Provides Update on Board Search and Audit & Risk Committee Composition
Published on 12/06/2025 at 01:15, 16 hours 35 minutes ago

Prospect Ridge Announces Closing of Flow-Through Unit Private Placement
Published on 12/06/2025 at 00:25, 17 hours 25 minutes ago

GMV Minerals Announces Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
Published on 12/06/2025 at 00:00, 17 hours 50 minutes ago

Bird River Announces Closing of $0.10 Common Share Financing
Published on 12/05/2025 at 23:30, 18 hours 20 minutes ago

55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000

View all ACCESSWIRE

EQS Group

Published on 12/06/2025 at 16:45, 1 hour 5 minutes ago

Blokees exhibits at CCXP25 in Brazil: World Premiere of the New Saint Seiya Product
Published on 12/06/2025 at 16:30, 1 hour 20 minutes ago

Döhler Opens New R&D Centre in Shanghai to Accelerate Innovation across Asia-Pacific
Published on 12/05/2025 at 22:15, 19 hours 35 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 19 hours 38 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 22 hours 52 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid

Les Echos

Published on 12/06/2025 at 13:26, 4 hours 24 minutes ago

Total number of voting rights and shares making up the share capital at November30, 2025
Published on 12/06/2025 at 13:26, 4 hours 24 minutes ago

Capital et droits de vote au 30 novembre 2025
Published on 12/05/2025 at 23:00, 18 hours 50 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 18 hours 50 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 18 hours 50 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025

View all LES ECHOS COMFI WIRE